The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 05, 2019
Filed:
Apr. 13, 2015
Applicants:
Emory University, Atlanta, GA (US);
Children's Healthcare of Atlanta, Inc., Atlanta, GA (US);
Inventors:
Jacques Galipeau, Atlanta, GA (US);
Andrea Pennati, Atlanta, GA (US);
Assignees:
Emory University, Atlanta, GA (US);
Children's Healthcare of Atlanta, Inc., Atlanta, GA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/19 (2006.01); A61K 38/20 (2006.01); C07K 14/535 (2006.01); A61K 35/17 (2015.01); C07K 14/54 (2006.01); C07K 14/55 (2006.01); A61K 39/00 (2006.01); A61K 45/06 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/535 (2013.01); A61K 35/17 (2013.01); A61K 39/0008 (2013.01); A61K 45/06 (2013.01); C07K 14/5406 (2013.01); C07K 14/5425 (2013.01); C07K 14/5443 (2013.01); C07K 14/55 (2013.01); A61K 38/00 (2013.01); A61K 2039/515 (2013.01); C07K 2319/00 (2013.01);
Abstract
This disclosure relates to recombinant proteins comprising a GM-CSF sequence and an interleukin sequence and nucleic acids related thereto. In certain embodiments, the disclosure relates to recombinant proteins comprises N-terminal sequences that are the result of improved production techniques and uses for treating or preventing autoimmune diseases such as multiple sclerosis and cancer.